So I think one helpful way to think about this is if the drug is working so aggressively that you cant nourish yourself, cant train well, and dont feel like yourself, thats not automatically a win
Recent reports have shown that GLP-1 receptor agonists such as liraglutide and semaglutide, which are currently approved for treating type 2 diabetes, decrease alcohol-seeking behaviors by inhibiting the mesolimbic reward system of the brain
World J Hepatol 7:16521659 Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes
The Ozempic Lawsuit is evolving, with legal proceedings centered on severe gastrointestinal injuries allegedly caused by Ozempic and other GLP-1 receptor agonist medications
It could even be counterproductive if it prevents patients from receiving the cardiovascular and metabolic benefits of these agents
Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis